Prognostic factors for survival of patients on the liver transplant waiting list
https://doi.org/10.29001/2073-8552-2020-35-1-70-79
Abstract
Aim. A single-center prospective cohort study was conducted to identify the factors determining the survival of patients with end-stage liver disease (ESLD) who were on the waiting list for liver transplantation.
Material and Methods. A total of 112 patients were examined including 28 individuals who died within six months of followup. The mean score of the model for end-stage liver disease (MELD) was 26.4 ± 3.72 (16–36) among the deceased.
Results. Compared to survivors, the deceased patients with end-stage liver diseases had higher incidences of complex heart rhythm disorders. These conditions include runs of supraventricular and ventricular tachycardia, episodes of ventricular trigeminy, a higher number of supraventricular extrasystoles, and the changes in QTc interval duration and QTc interval dispersion. The study showed that compared to the liver transplant recipients that survived, the casualties showed some common characteristics such as lower values of tricuspid valve annular plane systolic excursion; increased values of right heart size, inferior vena cava diameter, peak tricuspid regurgitation velocity, and systolic pressure in the pulmonary artery; decreased ratio of transtricuspid flow velocity in the early diastole to flow velocity in the right atrial systole phase; and higher values of troponin I [0.60 (0.14–1.00) ng/mL vs. 0.24 (0.095–0.465) ng/mL, p = 0.024] and NTproBNP [125.0 (74.0–187.5) pg/mL vs. 82.0 (25.0–125.0) pg/mL, p = 0.011].
Conclusions. Heart rate, troponin I level, and NTproBNP value were identified as additional factors determining the risk of adverse outcomes in liver failure patients on the waiting list for liver transplantation. The study resulted in the development of an informative and efficient mathematical model allowing for assessment of sudden death risk in liver failure patients on the waiting list for liver transplantation.
Material and Methods. A total of 112 patients were examined including 28 individuals who died within six months of followup. The mean score of the model for end-stage liver disease (MELD) was 26.4 ± 3.72 (16–36) among the deceased.
Results. Compared to survivors, the deceased patients with end-stage liver diseases had higher incidences of complex heart rhythm disorders. These conditions include runs of supraventricular and ventricular tachycardia, episodes of ventricular trigeminy, a higher number of supraventricular extrasystoles, and the changes in QTc interval duration and QTc interval dispersion. The study showed that compared to the liver transplant recipients that survived, the casualties showed some common characteristics such as lower values of tricuspid valve annular plane systolic excursion; increased values of right heart size, inferior vena cava diameter, peak tricuspid regurgitation velocity, and systolic pressure in the pulmonary artery; decreased ratio of transtricuspid flow velocity in the early diastole to flow velocity in the right atrial systole phase; and higher values of troponin I [0.60 (0.14–1.00) ng/mL vs. 0.24 (0.095–0.465) ng/mL, p = 0.024] and NTproBNP [125.0 (74.0–187.5) pg/mL vs. 82.0 (25.0–125.0) pg/mL, p = 0.011].
Conclusions. Heart rate, troponin I level, and NTproBNP value were identified as additional factors determining the risk of adverse outcomes in liver failure patients on the waiting list for liver transplantation. The study resulted in the development of an informative and efficient mathematical model allowing for assessment of sudden death risk in liver failure patients on the waiting list for liver transplantation.
About the Authors
E. A. Grigorenko
Belarusian State Medical University
Belarus
Cand. Sci. (Med.), Associate Professor, Department of Cardiology and Internal Medicine
83, Dzerzhinsky ave., Minsk, 220116, Republic of Belarus
Belarus
Cand. Sci. (Med.), Associate Professor, Department of Cardiology and Internal Medicine
83, Dzerzhinsky ave., Minsk, 220116, Republic of Belarus
N. P. Mitkovskaya
Belarusian State Medical University
Belarus
Dr. Sci. (Med.), Professor, Head of the Department of Cardiology and Internal Medicine
83, Dzerzhinsky ave., Minsk, 220116, Republic of Belarus
Belarus
Dr. Sci. (Med.), Professor, Head of the Department of Cardiology and Internal Medicine
83, Dzerzhinsky ave., Minsk, 220116, Republic of Belarus
O. O. Rummo
Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology
Belarus
Belarus
Dr. Sci. (Med.), Professor, Corresponding Member of the National Academy of Sciences of Belarus, Director
8, Semashko str., Minsk, 220116, Republic of Belarus
References
1. Yoshida M., Kinoshita Y., Watanabe M., Sugano K. JSGE clinical practice guidelines 2014: standards, methods, and process of developing the guidelines. J. Gastroenterol. 2015;50(1):4–10. DOI: 10.1007/s00535-014-1016-1.
2. Gleeson D., Heneghan M.A. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60(12):1611–1629. DOI: 10.1136/gut.2010.235259.
3. Grigorenko E.A., Rummo O.O., Mitkovskaya N.P. Prognostic assessment of posttransplantation survival of liver transplant recipients. Emergency Cardiology and Cardiovascular Risks. 2017;1(1):72–77 (In Russ.).
4. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R.B., Port F.K., Wolfe R.A. The survival benefit of liver transplantation. Am. J. Transplant. 2005;5(2):307–313.
5. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 2010;53(3):397–417. DOI: 10.1016/j.jhep.2010.05.004.
6. Moreau R., Jalan R., Gines P., Pavesi M., Angeli P., Cordoba J. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–1437,1437.e1-9. DOI: 10.1053/j.gastro.2013.02.042.
7. Jalan R., Saliba F., Pavesi M., Amoros A., Moreau R., Ginès P. et al. Development and validation of a prognostic score to predict mortality in patients with acute-onchronic liver failure. J. Hepatol. 2014;61(5):1038–1047. DOI: 10.1016/j.jhep.2014.06.012.
8. Ishigami M., Honda T., Okumura A., Ishikawa T., Kobayashi M., Katano Y. et al. Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. J. Gastroenterol. 2008;43(5):363–368. DOI: 10.1007/s00535-008-2168-7.
9. Das V., Boelle P.Y., Galbois A., Guidet B., Maury E., Carbonell N. et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit. Care Med. 2010;38(11):2108–2116. DOI: 10.1097/CCM.0b013e3181f3dea9.
10. Gustot T., Fernandez J., Garcia E., Morando F., Caraceni P., Alessandria C. et al. Clinical course of acute on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243–252. DOI: 10.1002/hep.27849.
Review
For citations:
Grigorenko E.A., Mitkovskaya N.P., Rummo O.O. Prognostic factors for survival of patients on the liver transplant waiting list. Siberian Journal of Clinical and Experimental Medicine. 2020;35(1):70-79. (In Russ.) https://doi.org/10.29001/2073-8552-2020-35-1-70-79
Views:
511
.png)
Email this article 